Baseline insulin/glucose ratio as a marker for the clinical course of hyperglycemic critically ill children treated with insulin

Nutrition

Volumn 28, Issue 1, 2012, Pages 25-29

  Verhoeven, Jennifer J ^a   Koenraads, Marianne ^a   Hop, Wim C J ^b   Brand, Jeannette B ^a   van de Polder, Mirjam M ^a   Joosten, Koen F M ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Critical illness; Hyperglycemia; Insulin sensitivity; Pediatric intensive care unit; Pediatrics

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CREATININE; FATTY ACID; GLUCOCORTICOID; GLUCOSE; HYDROCORTISONE; INSULIN; PREDNISOLONE; UREA;

ADOLESCENT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GLUCOSE MONITORING; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPOINSULINEMIA; INFANT; INSULIN SENSITIVITY; INSULIN TREATMENT; INTENSIVE CARE; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL SUPPORT; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SCHOOL CHILD; SURVIVAL RATE; TREATMENT DURATION;

ADOLESCENT; ALGORITHMS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; DRUG MONITORING; FEMALE; HOSPITALS, PEDIATRIC; HOSPITALS, UNIVERSITY; HUMANS; HYPERGLYCEMIA; HYPERINSULINISM; INFANT; INSULIN; INSULIN RESISTANCE; INTENSIVE CARE UNITS, PEDIATRIC; LENGTH OF STAY; MALE; NETHERLANDS; PROSPECTIVE STUDIES; RESPIRATORY INSUFFICIENCY;

EID: 83355166851     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2011.04.005     Document Type: Article

References (20)

1. Verbruggen S.C., Joosten K.F., Castillo L., van Goudoever J.B. Insulin therapy in the pediatric intensive care unit. Clin Nutr 2007, 26:677-690.
2. Collier B., Dossett L.A., May A.K., Diaz J.J. Glucose control and the inflammatory response. Nutr Clin Pract 2008, 23:3-15.
3. Saberi F., Heyland D., Lam M., Rapson D., Jeejeebhoy K. Prevalence, incidence, and clinical resolution of insulin resistance in critically ill patients: an observational study. JPEN 2008, 32:227-235.
4. van Waardenburg D.A., Jansen T.C., Vos G.D., Buurman W.A. Hyperglycemia in children with meningococcal sepsis and septic shock: the relation between plasma levels of insulin and inflammatory mediators. J Clin Endocrinol Metab 2006, 91:3916-3921.
5. Preissig C.M., Rigby M.R. Hyperglycaemia results from beta-cell dysfunction in critically ill children with respiratory and cardiovascular failure: a prospective observational study. Crit Care 2009, 13:R27.
6. Vlasselaers D., Milants I., Desmet L., Wouters P.J., Vanhorebeek I., van den Heuvel I., et al. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet 2009, 373:547-556.
7. Verhoeven J.J., Brand J.B., van de Polder M.M., Joosten K.F. Management of hyperglycemia in the pediatric intensive care unit; implementation of a glucose control protocol. Pediatr Crit Care Med 2009, 10:648-652.
8. Pollack M.M., Ruttimann U.E., Getson P.R. Pediatric Risk of Mortality (PRISM) score. Crit Care Med 1988, 16:1110-1116.
9. Leteurtre S., Martinot A., Duhamel A., Proulx F., Grandbastien B., Cotting J., et al. Validation of the Paediatric Logistic Organ Dysfunction (PELOD) score: prospective, observational, multicentre study. Lancet 2003, 362:192-197.
10. Hatherill M., Tibby S.M., Hilliard T., Turner C., Murdoch I.A. Adrenal insufficiency in septic shock. Arch Dis Child 1999, 80:51-55.
11. Ista E., Joosten K. Nutritional assessment and enteral support of critically ill children. Crit Care Nurs Clin North Am 2005, 17:385-393.
12. Conwell L.S., Trost S.G., Brown W.J., Batch J.A. Indexes of insulin resistance and secretion in obese children and adolescents: a validation study. Diabetes Care 2004, 27:314-319.
13. Vuguin P., Saenger P., Dimartino-Nardi J. Fasting glucose insulin ratio: a useful measure of insulin resistance in girls with premature adrenarche. J Clin Endocrinol Metab 2001, 86:4618-4621.
14. Wallace T.M., Levy J.C., Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 2004, 27:1487-1495.
15. Parker M.M., Hazelzet J.A., Carcillo J.A. Pediatric considerations. Crit Care Med 2004, 32(11 suppl):S591-S594.
16. Thomas Z., Bandali F., McCowen K., Malhotra A. Drug-induced endocrine disorders in the intensive care unit. Crit Care Med 2010, 38(6 suppl):S219-S230.
17. der Voort P.H., Feenstra R.A., Bakker A.J., Heide L., Boerma E.C., van der Horst I.C. Intravenous glucose intake independently related to intensive care unit and hospital mortality: an argument for glucose toxicity in critically ill patients. Clin Endocrinol (Oxf) 2006, 64:141-145.
18. Zarkovic M., Beleslin B., Ciric J., Penezic Z., Stojkovic M., Trbojevic B., et al. Glucocorticoid effect on insulin sensitivity: a time frame. J Endocrinol Invest 2008, 31:238-242.
19. Mizock B.A. Blood glucose management during critical illness. Rev Endocr Metab Disord 2003, 31:187-194.
20. Bouwmeester N.J., Anand K.J., van Dijk M., Hop W.C., Boomsma F., Tibboel D. Hormonal and metabolic stress responses after major surgery in children aged 0-3 years: a double-blind, randomized trial comparing the effects of continuous versus intermittent morphine. Br J Anaesth 2001, 87:390-399.